Michael Roemeris a film director, producer and writer. He has won several awards for his films. He is the recipient of a Guggenheim Fellowship. A professor at Yale University, he is the author of Telling Stories... (wikipedia)
Irrespective of the management board's recommendation, the decision to accept our offer lies with the shareholders. We are confident that they will consider this offer, which represents full and immediate value as attractive.
We are still convinced that a combination would have been a good option for both companies.
This is an ideal merger for both companies.
This is an ideal combination for both companies. It provides both companies with the unique opportunity to take a quantum leap and become more competitive and continue to thrive in the consolidating global pharmaceuticals industry.